Agilent Technologies (A) Stock Price, News & Analysis

Company Overview

Agilent Technologies Inc., headquartered in Santa Clara, California, is a leading provider of scientific instruments, software, services and consumables for the entire laboratory workflow. Established in 1999 through the spinoff of Hewlett-Packard’s analytical instruments business, Agilent has grown into a global innovator in life sciences, diagnostics and applied chemical markets. The company’s offerings support a wide range of analytical and diagnostic applications, enabling customers to gain precise insights into the composition, structure and function of complex biological and chemical systems.

Agilent’s product portfolio spans chromatography and mass spectrometry systems, spectroscopy instruments, microarrays, cell analysis tools and automation platforms. Its CrossLab segment delivers services and consumables that help customers optimize instrument performance, from installation and validation to training and maintenance. The Diagnostics and Genomics group, bolstered by the 2012 acquisition of Dako, provides reagents and instruments for molecular pathology, companion diagnostics and genomic research. In 2019, the company further expanded its reach in life science instrumentation through the acquisition of BioTek Instruments, enhancing its capabilities in microplate readers, washers and automated liquid handling.

The company serves a diverse global customer base across pharmaceuticals, biotechnology, academia, food safety, environmental testing, forensics and electronics manufacturing. Agilent maintains a presence in over 30 countries, with manufacturing, R&D and support centers in North America, Europe and the Asia-Pacific region. Its instruments and solutions play a critical role in drug discovery, clinical diagnostics, environmental monitoring and quality control processes worldwide.

Under the leadership of President and Chief Executive Officer Michael R. McMullen, who joined Agilent in 2009 and was appointed CEO in 2014, the company has focused on advancing scientific discovery through strategic investments in R&D and targeted acquisitions. Agilent’s management team continues to prioritize innovation, operational excellence and customer-centric service to drive long-term growth and maintain its position at the forefront of analytical science.

Key Stats

• Today's Range: $126.38 to $130.08
• 50-Day Range: $112.12 to $128.69
• 52-Week Range: $96.43 to $153.84
• Volume: 1.92 million shs
• Average Volume: 1.95 million shs
• Market Capitalization: $35.98 billion
• P/E Ratio: 29.79
• Dividend Yield: 0.78%
• Price Target: $140.08
• Consensus Rating: Moderate Buy

Agilent Technologies Stock Analysis - MarketRank™

Agilent Technologies scored higher than 89% of companies evaluated by MarketBeat, and ranked 108th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Agilent Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.

Upside Potential

Agilent Technologies has a consensus price target of $140.08, representing about 10.4% upside from its current price of $126.91.

Amount of Analyst Coverage

Agilent Technologies has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.96%

Earnings Growth

Earnings for Agilent Technologies are expected to grow by 8.96% in the coming year, from $5.58 to $6.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilent Technologies is 29.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilent Technologies is 29.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.67.

Price to Earnings Growth Ratio

Agilent Technologies has a PEG Ratio of 3.91. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Agilent Technologies has a P/B Ratio of 5.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.08% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently increased by 5.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Agilent Technologies has a dividend yield of 0.79%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Agilent Technologies has been increasing its dividend for 9 years.

Dividend Coverage

The dividend payout ratio of Agilent Technologies is 23.24%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 16.28% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.83

Percentage of Shares Shorted

1.08% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently increased by 5.56%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.86

News Sentiment

Agilent Technologies has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 43 news articles for Agilent Technologies this week, compared to 26 articles on an average week.

Search Interest

69 people have searched for A on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.

MarketBeat Follows

Only 4 people have added Agilent Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Agilent Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $178,032.00 in company stock.

A Stock Analysis - Frequently Asked Questions

How have A shares performed this year?

Agilent Technologies' stock was trading at $134.34 at the beginning of 2025. Since then, A shares have decreased by 5.5% and is now trading at $126.9130.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its earnings results on Wednesday, August, 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. The firm's revenue was up 10.1% on a year-over-year basis.
Read the conference call transcript.

Does Agilent Technologies have any subsidiaries?

Agilent Technologies subsidiaries include Resolution Bioscience, BioTek Instruments, ACEA BIO, Young In Scientific Co. Ltd, ProZyme Inc, ULTRA Scientific, Genohm, and more.

Who are Agilent Technologies' major shareholders?

Top institutional shareholders of Agilent Technologies include Vanguard Group Inc. (11.97%), Massachusetts Financial Services Co. MA (4.66%), State Street Corp (4.38%) and Geode Capital Management LLC (2.58%). Insiders that own company stock include Michael R Mcmullen, Jacob Thaysen, Henrik Ancher-Jensen, Boon Hwee Koh, Heidi Fields, Michael Tang, Dominique Grau, Padraig Mcdonnell, Daniel K Podolsky, Rodney Gonsalves, Philip Binns and Judy L Brown.
View institutional ownership trends.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilent Technologies investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Record date for 7/23 Dividend: 7/01/2025
• Ex-Dividend for 7/23 Dividend: 7/01/2025
• Dividend Payable: 7/23/2025
• Last Earnings: 8/27/2025
• Today: 9/17/2025
• Fiscal Year End: 10/31/2025
• Next Earnings (Estimated): 11/24/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:A
• CIK: 1090872
• Web: www.agilent.com
• Phone: (800) 227-9770
• Fax: 408-345-8474
• Employees: 17,900
• Year Founded: 1999

Price Target and Rating

• Average Price Target for Agilent Technologies: $140.08
• High Price Target: $165.00
• Low Price Target: $116.00
• Potential Upside/Downside: +9.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.26
• Trailing P/E Ratio: 30.03
• Forward P/E Ratio: 22.93
• P/E Growth: 3.91
• Net Income: $1.29 billion
• Net Margins: 17.97%
• Pretax Margin: 20.54%
• Return on Equity: 25.51%
• Return on Assets: 12.94%

Debt

• Debt-to-Equity Ratio: 0.53
• Current Ratio: 2.25
• Quick Ratio: 1.71

Sales & Book Value

• Annual Sales: $6.51 billion
• Price / Sales: 5.57
• Cash Flow: $6.37 per share
• Price / Cash Flow: 20.10
• Book Value: $22.47 per share
• Price / Book: 5.70

Miscellaneous

• Outstanding Shares: 283,500,000
• Free Float: N/A
• Market Cap: $36.28 billion
• Optionable: Optionable
• Beta: 1.24